TNFRSF10B and gastric cancer: Casticin (63) enhanced TNFRSF10B expression, suggesting that TNFRSF10B upregulation is a potential mechanism via which this compound (63) increases the apoptotic impacts of TNFRSF10A in GC cells, BGC-823.